ArticleCancer medicine2025

Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System.

Shaimaa Elshafie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.